Sinotherapeutics Inc banner
S

Sinotherapeutics Inc
SSE:688247

Watchlist Manager
Sinotherapeutics Inc
SSE:688247
Watchlist
Price: 9.59 CNY 1.05% Market Closed
Market Cap: ¥4.3B

Sinotherapeutics Inc
Investor Relations

Sinotherapeutics, Inc. engages in the research and development, production and sales of high-end generic drugs and Contract Research Organization (CRO) services. The company is headquartered in Shanghai, Shanghai and currently employs 248 full-time employees. The company went IPO on 2022-08-25. The firm's main businesses include research and development, production and sales of generic drugs, as well as contract research and development organization (CRO) services. The firm mainly operates in the domestic market and overseas markets.

Show more
Loading
688247
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Kun Li
Deputy General Manager
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
Room 205, 207, No.515 Huanke Road, China (Shanghai) Pilot Free Trade Zone
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett